$ACTG
ACACIA RESEARCH CORP

2024 Q3 Form 10-Q Financial Statement

#000093454924000063 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $23.31M $25.84M
YoY Change 131.16% 226.9%
Cost Of Revenue $20.96M $19.08M
YoY Change 112.85% 113.35%
Gross Profit $2.351M $6.758M
YoY Change 891.98% -750.43%
Gross Profit Margin 10.09% 26.16%
Selling, General & Admin $12.52M $11.34M
YoY Change -19.18% 0.47%
% of Gross Profit 532.33% 167.77%
Research & Development $108.0K $178.0K
YoY Change -37.21% -13.17%
% of Gross Profit 4.59% 2.63%
Depreciation & Amortization $9.762M $7.405M
YoY Change 187.12% 117.28%
% of Gross Profit 415.23% 109.57%
Operating Expenses $12.62M $11.52M
YoY Change -19.38% 0.23%
Operating Profit -$10.27M -$4.758M
YoY Change -33.39% -62.02%
Interest Expense $6.112M -$4.519M
YoY Change -66.03% -42.76%
% of Operating Profit
Other Income/Expense, Net $4.112M -$11.13M
YoY Change -77.14% 41.0%
Pretax Income -$6.160M -$15.89M
YoY Change -340.16% -22.2%
Income Tax $5.497M -$7.061M
% Of Pretax Income
Net Earnings -$14.00M -$8.446M
YoY Change -955.5% -55.02%
Net Earnings / Revenue -60.04% -32.69%
Basic Earnings Per Share -$0.14 -$0.08
Diluted Earnings Per Share -$0.14 -$0.08
COMMON SHARES
Basic Shares Outstanding 100.4M shares 100.0M shares
Diluted Shares Outstanding 99.85M shares 100.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $410.9M $441.9M
YoY Change -7.87% -0.65%
Cash & Equivalents $360.1M $387.0M
Short-Term Investments $50.85M $54.92M
Other Short-Term Assets $23.80M $20.96M
YoY Change 17.8% 1.12%
Inventory $12.22M $12.29M
Prepaid Expenses
Receivables $10.73M $18.77M
Other Receivables $0.00 $0.00
Total Short-Term Assets $457.6M $493.9M
YoY Change -5.53% 1.68%
LONG-TERM ASSETS
Property, Plant & Equipment $2.366M $2.315M
YoY Change -10.62% -21.53%
Goodwill $8.990M $8.990M
YoY Change 19.21% 19.21%
Intangibles $30.87M $36.02M
YoY Change 12.03% 17.74%
Long-Term Investments $30.93M $30.93M
YoY Change 0.0% 0.0%
Other Assets $7.759M $4.257M
YoY Change 50.78% -38.53%
Total Long-Term Assets $249.9M $259.7M
YoY Change 459.12% 430.83%
TOTAL ASSETS
Total Short-Term Assets $457.6M $493.9M
Total Long-Term Assets $249.9M $259.7M
Total Assets $707.6M $753.6M
YoY Change 33.72% 40.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.258M $3.191M
YoY Change -38.36% -44.88%
Accrued Expenses $12.44M $32.40M
YoY Change 32.33% 259.08%
Deferred Revenue $1.268M $911.0K
YoY Change 10.36% -10.86%
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.92M $44.20M
YoY Change 30.26% -43.19%
LONG-TERM LIABILITIES
Long-Term Debt $70.00M $82.00M
YoY Change
Other Long-Term Liabilities $1.771M $1.479M
YoY Change -15.02% -20.4%
Total Long-Term Liabilities $1.771M $1.479M
YoY Change -15.02% -20.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.92M $44.20M
Total Long-Term Liabilities $1.771M $1.479M
Total Liabilities $129.0M $156.8M
YoY Change 404.94% -10.94%
SHAREHOLDERS EQUITY
Retained Earnings -$262.4M -$248.4M
YoY Change -16.58% -21.43%
Common Stock $99.00K $100.0K
YoY Change 0.0% 72.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $105.6M $98.26M
YoY Change 7.43% 0.0%
Treasury Stock Shares
Shareholders Equity $540.2M $560.7M
YoY Change
Total Liabilities & Shareholders Equity $707.6M $753.6M
YoY Change 33.72% 40.94%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$14.00M -$8.446M
YoY Change -955.5% -55.02%
Depreciation, Depletion And Amortization $9.762M $7.405M
YoY Change 187.12% 117.28%
Cash From Operating Activities -$571.0K $16.12M
YoY Change -151.91% -209.09%
INVESTING ACTIVITIES
Capital Expenditures $7.234M $151.9M
YoY Change 7134.0% 281146.3%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$7.234M -$151.9M
YoY Change 1105.67% -2460.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.30M 84.05M
YoY Change 77.09% -12589.45%
NET CHANGE
Cash From Operating Activities -571.0K 16.12M
Cash From Investing Activities -7.234M -151.9M
Cash From Financing Activities -19.30M 84.05M
Net Change In Cash -27.11M -51.70M
YoY Change 160.65% 473.78%
FREE CASH FLOW
Cash From Operating Activities -$571.0K $16.12M
Capital Expenditures $7.234M $151.9M
Free Cash Flow -$7.805M -$135.8M
YoY Change -880.5% 815.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-31445000 usd
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
9960000 usd
CY2024Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-4744000 usd
CY2023Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-1382000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589604000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1447000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1736000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1479000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4039000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
156848000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
43936000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-9935000 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100375459 shares
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14500000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44204000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27636000 usd
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
27718000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
0 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
82000000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
10525000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100375459 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99895473 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99895473 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16183703 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16183703 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
98258000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
98258000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
907215000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
906153000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-248361000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239729000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
560696000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
568266000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
36049000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
21343000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
596745000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589609000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
753593000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
633545000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50158000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22707000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
312000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
421000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2942000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3772000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22304000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21466000 usd
us-gaap Costs And Expenses
CostsAndExpenses
57003000 usd
us-gaap Costs And Expenses
CostsAndExpenses
44560000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6845000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21853000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
28861000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-9360000 usd
CY2024Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
6613000 usd
CY2023Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-70000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
15000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-88000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
95000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
900000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1800000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
295000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4307000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5185000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7748000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11132000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7895000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10343000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13359000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15890000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20424000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17188000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8494000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7061000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1645000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8170000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
838000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-8829000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-18779000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9018000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9332000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-383000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-386000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8446000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18779000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8632000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9332000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8446000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21155000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8632000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13962000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100079803 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58408711 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99912854 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53219152 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8446000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21155000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8632000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13962000 usd
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
100079803 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
58408711 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
99912854 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
53219152 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-8829000 usd
CY2024Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
15250000 usd
CY2024Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
223000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
394000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
891000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
596745000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355687000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-18779000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1676000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
700000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
206000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
179000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
596745000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
269322000 usd
us-gaap Profit Loss
ProfitLoss
-9332000 usd
us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
3230000 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
1400000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
206000 usd
actg Issuance Of Common Stock From The Rights Offering
IssuanceOfCommonStockFromTheRightsOffering
79111000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
595000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1351000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
335433000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9018000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9332000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11973000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6789000 usd
actg Accretion Of Asset Retirement Obigation
AccretionOfAssetRetirementObigation
-254000 usd
actg Accretion Of Asset Retirement Obigation
AccretionOfAssetRetirementObigation
0 usd
actg Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
0 usd
actg Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
3954000 usd
actg Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
0 usd
actg Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
2762000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1749000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1351000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-88000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
95000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-31445000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
9960000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
28861000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-9360000 usd
actg Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
-3401000 usd
actg Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
0 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-10939000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-617000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-61727000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2629000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1368000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-216000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3949000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1765000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20529000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10624000 usd
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
-5917000 usd
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
-120000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-159000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-238000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70955000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19122000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15544000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5843000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
57854000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
15198000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143143000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109833000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9218000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
15250000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
71475000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1400000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1068000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
595000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
223000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
206000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85880000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77322000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-105000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-16000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46897000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67402000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
340091000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
287786000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
386988000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355188000 usd
us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
449000 usd
us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
1800000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
384000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
551000 usd
actg Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
5000000 usd
actg Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
0 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61123595 shares
actg Number Of Patent Portfolios Acquired
NumberOfPatentPortfoliosAcquired
0 patent
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
441000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
567000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.44
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.08
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.48
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
CY2024Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
757000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
19971000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
4000 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
1801000 usd
CY2024Q2 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
18174000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
33423000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
29680000 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
35000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
63068000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3805000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3961000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1303000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1882000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7730000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5578000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
12838000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
11421000 usd
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
549000 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
500000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
12289000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10921000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5182000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4760000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2867000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2404000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2315000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2356000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
277000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
374000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
557000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
721000 usd
CY2024Q2 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
191838000 usd
CY2023Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
25276000 usd
CY2024Q2 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
4786000 usd
CY2023Q4 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
0 usd
CY2024Q2 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
4037000 usd
CY2023Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
159000 usd
CY2024Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
192587000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
25117000 usd
CY2024Q2 actg Oil And Gas Depreciation And Depletion Expense
OilAndGasDepreciationAndDepletionExpense
3500000 usd
actg Oil And Gas Depreciation And Depletion Expense
OilAndGasDepreciationAndDepletionExpense
3900000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
8990000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q2 us-gaap Goodwill
Goodwill
8990000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
7541000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1449000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
8990000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
363533000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
327516000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36017000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
353533000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
319977000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33556000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3700000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6100000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
actg Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
0 usd
actg Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
10291000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18485000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4173000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1734000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1334000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36017000 usd
CY2024Q2 actg Accrued Patent Investment Costs
AccruedPatentInvestmentCosts
15000000.0 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000.0 usd
CY2024Q2 actg Patent Investments Costs Accrued
PatentInvestmentsCostsAccrued
10000000.0 usd
CY2024Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5000000.0 usd
CY2024Q2 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
5000000 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000.0 usd
CY2024Q2 actg Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
850000 usd
CY2023Q4 actg Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
1595000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1294000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
619000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1570000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
106000 usd
CY2024Q2 actg Operating Lease Accrued Expense
OperatingLeaseAccruedExpense
3488000 usd
CY2023Q4 actg Operating Lease Accrued Expense
OperatingLeaseAccruedExpense
0 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
36000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
30000 usd
CY2024Q2 actg Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
365000 usd
CY2023Q4 actg Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
169000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
990000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1248000 usd
CY2024Q2 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
5000000 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000 usd
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1614000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
638000 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
15207000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
8405000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
294000 usd
us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
28713000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
254000 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
29261000 usd
CY2024Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
1543000 usd
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
27718000 usd
CY2023Q3 actg Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
55000000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61123595 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99886322 shares
CY2023Q3 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
27704 shares
CY2023Q3 actg Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
55000000 usd
CY2023Q3 actg Class Of Warrant Or Right Recapitalization Payment
ClassOfWarrantOrRightRecapitalizationPayment
66000000 usd
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
678000 usd
us-gaap Legal Fees
LegalFees
14000 usd
us-gaap Legal Fees
LegalFees
97000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
589000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
588000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
552000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1014000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
601000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
270000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2437000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
990000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1447000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14500000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14500000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
12900000 usd
actg Ownership Percent Of Voting Stock
OwnershipPercentOfVotingStock
0.10
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
995000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
521000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4000000.0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y6M
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8446000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18779000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8632000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9332000 usd
CY2024Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
700000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1400000 usd
CY2024Q2 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 usd
CY2023Q2 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1676000 usd
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 usd
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
3230000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8446000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21155000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8632000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13962000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8446000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21155000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8632000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13962000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100079803 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58408711 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99912854 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53219152 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100079803 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58408711 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99912854 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53219152 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3898180 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36265921 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3898180 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36265921 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25838000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50158000 usd
CY2024Q2 us-gaap Royalty Expense
RoyaltyExpense
802000 usd
us-gaap Royalty Expense
RoyaltyExpense
1408000 usd
CY2024Q2 actg Contingent Legal Fees
ContingentLegalFees
571000 usd
actg Contingent Legal Fees
ContingentLegalFees
2395000 usd
CY2024Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
1152000 usd
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
2290000 usd
CY2024Q2 actg Amortization Of Patents
AmortizationOfPatents
3240000 usd
actg Amortization Of Patents
AmortizationOfPatents
6673000 usd
CY2024Q2 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
3277000 usd
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
7326000 usd
CY2024Q2 us-gaap Production Costs
ProductionCosts
10038000 usd
us-gaap Production Costs
ProductionCosts
11353000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
19080000 usd
us-gaap Cost Of Revenue
CostOfRevenue
31445000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
6758000 usd
us-gaap Gross Profit
GrossProfit
18713000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4758000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6845000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11132000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10343000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15890000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17188000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7904000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22707000 usd
CY2023Q2 us-gaap Royalty Expense
RoyaltyExpense
145000 usd
us-gaap Royalty Expense
RoyaltyExpense
366000 usd
CY2023Q2 actg Contingent Legal Fees
ContingentLegalFees
12000 usd
actg Contingent Legal Fees
ContingentLegalFees
544000 usd
CY2023Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
2253000 usd
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
3637000 usd
CY2023Q2 actg Amortization Of Patents
AmortizationOfPatents
2600000 usd
actg Amortization Of Patents
AmortizationOfPatents
5201000 usd
CY2023Q2 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
3933000 usd
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
9153000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
8943000 usd
us-gaap Cost Of Revenue
CostOfRevenue
18901000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-1039000 usd
us-gaap Gross Profit
GrossProfit
3806000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12529000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21853000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7895000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13359000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20424000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8494000 usd
CY2024Q2 actg Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
18174000 usd
CY2023Q4 actg Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
63068000 usd
CY2024Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5816000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5816000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
30934000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
30934000 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
54924000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
99818000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
203728000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
218909000 usd
CY2024Q2 us-gaap Assets
Assets
753593000 usd
CY2023Q4 us-gaap Assets
Assets
633545000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25838000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50158000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7904000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22707000 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
194902000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
27473000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14500000 usd

Files In Submission

Name View Source Status
0000934549-24-000063-index-headers.html Edgar Link pending
0000934549-24-000063-index.html Edgar Link pending
0000934549-24-000063.txt Edgar Link pending
0000934549-24-000063-xbrl.zip Edgar Link pending
actg-20240630.htm Edgar Link pending
actg-20240630.xsd Edgar Link pending
actg-20240630xex311.htm Edgar Link pending
actg-20240630xex312.htm Edgar Link pending
actg-20240630xex321.htm Edgar Link pending
actg-20240630xex322.htm Edgar Link pending
actg-20240630_cal.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
actg-20240630_def.xml Edgar Link unprocessable
actg-20240630_lab.xml Edgar Link unprocessable
actg-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
actg-20240630_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending